SCHEMBL19190257

SCHEMBL19190257

CC(C)(C)OC(=O)N[C@H](Cc1ccc(-c2cc(Cl)ccc2F)cc1)CC(O)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.53
▸ ACE P12821 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17011376 1.00 MME (0.53) MMEACE
SCHEMBL20280997 0.91 MME (0.55) MMEACE
SCHEMBL16930520 0.91 MME (0.55) MMEACE
SCHEMBL18724752 0.89 MME (0.47) MME
SCHEMBL15939008 0.88 MME (0.62) MME
SCHEMBL2875545 0.88 MME (0.62) MME
SCHEMBL17409558 0.88 MME (0.46) MMEACE
SCHEMBL16942452 0.86 MME (0.48) MMEACE
SCHEMBL16932435 0.86 ACE (0.53) MMEACE
SCHEMBL16932436 0.86 ACE (0.53) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3199517-A1 NEPRILYSIN INHIBITORS Theravance Biopharma R&D IP, LLC (US) 2017-08-02 — — EP disclosed
Send feedback